89 related articles for article (PubMed ID: 19005144)
21. Use of PCR to estimate the prevalence of Equus caballus papillomavirus in aural plaques in horses.
Gorino AC; Oliveira-Filho JP; Taniwaki SA; Basso RM; Zakia LS; Araujo JP; Borges AS
Vet J; 2013 Sep; 197(3):903-4. PubMed ID: 23773810
[TBL] [Abstract][Full Text] [Related]
22. Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays.
Albrecht V; Chevallier A; Magnone V; Barbry P; Vandenbos F; Bongain A; Lefebvre JC; Giordanengo V
J Virol Methods; 2006 Nov; 137(2):236-44. PubMed ID: 16879879
[TBL] [Abstract][Full Text] [Related]
23. Analytical performance evaluation of the HPV OncoCheck assay for detection of high-risk HPV infection in liquid-based cervical samples.
Wang HY; Kim H; Park S; Park KH; Lee H
Exp Mol Pathol; 2019 Feb; 106():149-156. PubMed ID: 30605636
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
[TBL] [Abstract][Full Text] [Related]
25. Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.
Stevens MP; Rudland E; Garland SM; Tabrizi SN
J Clin Microbiol; 2006 Jul; 44(7):2428-33. PubMed ID: 16825360
[TBL] [Abstract][Full Text] [Related]
26. The presence of Y chromosomal deoxyribonucleic acid in the female vaginal swab: possible implications for human papillomavirus testing.
Baay MF; Francois K; Lardon F; Van Royen P; Pauwels P; Vermorken JB; Peeters M; Verhoeven V
Cancer Epidemiol; 2011 Feb; 35(1):101-3. PubMed ID: 21095173
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens.
Fontaine V; Mascaux C; Weyn C; Bernis A; Celio N; Lefèvre P; Kaufman L; Garbar C
J Clin Microbiol; 2007 Mar; 45(3):928-34. PubMed ID: 17229855
[TBL] [Abstract][Full Text] [Related]
28. Penile, urethral, and seminal sampling for diagnosis of human papillomavirus infection in men.
Giovannelli L; Migliore MC; Capra G; Caleca MP; Bellavia C; Perino A; Viviano E; Matranga D; Ammatuna P
J Clin Microbiol; 2007 Jan; 45(1):248-51. PubMed ID: 17093029
[TBL] [Abstract][Full Text] [Related]
29. Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.
Coutlée F; Provencher D; Voyer H
J Clin Microbiol; 1995 Aug; 33(8):1973-8. PubMed ID: 7559932
[TBL] [Abstract][Full Text] [Related]
30. DNA concentration from self samples for HPV testing.
Meza R; Lau YK; Thomas TB; Carey TE; Walline HM; Eisenberg MC
Int J Cancer; 2018 Dec; 143(11):3036-3037. PubMed ID: 29978468
[No Abstract] [Full Text] [Related]
31. [The development and clinical application of papillomavirus genotyping by DNA chip].
Yang G; Liang CH; Cui JH; Chen S
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jan; 27(1):47-9. PubMed ID: 16737573
[TBL] [Abstract][Full Text] [Related]
32. Comparison of three human papillomavirus DNA detection methods: Next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing.
da Fonseca AJ; Galvão RS; Miranda AE; Ferreira LC; Chen Z
J Med Virol; 2016 May; 88(5):888-94. PubMed ID: 26496186
[TBL] [Abstract][Full Text] [Related]
33. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay.
Giovannelli L; Lama A; Capra G; Giordano V; Aricò P; Ammatuna P
J Clin Microbiol; 2004 Aug; 42(8):3861-4. PubMed ID: 15297550
[TBL] [Abstract][Full Text] [Related]
34. [Detection of the human papillomavirus in samples obtained by self-collection technique in a group of peruvian college students].
Manrique-Hinojosa J; Núñez-Teran MDC; Pretel-Ydrogo L; Sullcahuaman-Allende Y; Roa-Meggo Y; Juárez-Coello P; Navarro-Egúsquiza S
Rev Peru Med Exp Salud Publica; 2018; 35(4):642-646. PubMed ID: 30726431
[TBL] [Abstract][Full Text] [Related]
35. Optimization of PCR based detection of human papillomavirus DNA from urine specimens.
Brinkman JA; Rahmani MZ; Jones WE; Chaturvedi AK; Hagensee ME
J Clin Virol; 2004 Apr; 29(4):230-40. PubMed ID: 15018850
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of human papillomavirus detection by Abbott m2000 system on samples collected by FTA Elute™ Card in a Chinese HIV-1 positive population.
Qin Y; Zhang H; Marlowe N; Fei M; Yu J; Lei X; Yu L; Zhang J; Cao D; Ma L; Chen W
J Clin Virol; 2016 Dec; 85():80-85. PubMed ID: 27846440
[TBL] [Abstract][Full Text] [Related]
37. Simple and rapid human papillomavirus genotyping method by restriction fragment length polymorphism analysis with two restriction enzymes.
Chen L; Watanabe K; Haruyama T; Kobayashi N
J Med Virol; 2013 Jul; 85(7):1229-34. PubMed ID: 23918541
[TBL] [Abstract][Full Text] [Related]
38. Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media.
Schutzbank TE; Jarvis C; Kahmann N; Lopez K; Weimer M; Yount A
J Clin Microbiol; 2007 Dec; 45(12):4067-9. PubMed ID: 17959755
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus genotyping using a modified linear array detection protocol.
Stevens MP; Garland SM; Tabrizi SN
J Virol Methods; 2006 Jul; 135(1):124-6. PubMed ID: 16564098
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the possible inhibitory effect of carrageenan in human papillomavirus DNA testing by polymerase chain reaction amplification.
Laurie C; El-Zein M; Franco EL; Coutlée F
J Med Virol; 2021 Nov; 93(11):6408-6411. PubMed ID: 33760280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
